Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Horizon Genomics

Horizon Genomics
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of biotechnological services. The company specializes in managing human cell products such as haploid human cell lines used to generate model cell lines for functional genomics studies.

Formerly Known As
Haplogen Genomics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Campus Vienna Biocenter 5
  • Vienna, 1030
  • Austria

Horizon Genomics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Horizon Genomics‘s full profile, request access.

Request full access to PitchBook

Horizon Genomics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ToolGen Corporation Seoul, South Korea 00
0000000 0000000000 Venture Capital-Backed Berkeley, CA 00 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000000 0000
00000000 Venture Capital-Backed Redwood City, CA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Beijing, China 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Horizon Genomics Executive Team (2)

Name Title Board
Seat
Contact
Info
Darrin Disley Ph.D Co-Chief Executive Officer
Thomas Moser Ph.D General Manager